Antibody response in cattle vaccinated against bluetongue serotype 8 in Italy.
作者： P. Calistri , A. Giovannini , G. Savini , L. Bonfanti , P. Cordioli
DOI: 10.1111/J.1865-1682.2010.01136.X
关键词:
摘要: Summary To assess the immunogenicity of Zulvac ! 8 Bovis (a commercial inactivated vaccine against bluetongue virus serotype ‐ BTV8) under field conditions, 71 cattle vaccinated according to manufacturer schedule in Verona province (Italy) were tested for presence BTV8 neutralizing antibodies at 21, 29, 36, 43, 49, 102 and 201 days post-vaccination (dpv). Another group 528 Mantova was also once between 113 174 dpv. The able elicit an immune response 69 (97.2%) 346 (65.5%) animals groups, respectively.
cabdirect.org
sci-hub.se 参考文章(19)
A. Giovannini, U. Santucci, V. Caporale, D. Nannini, C. Patta, P. Calistri, Vaccination in the control strategy of bluetongue in Italy. Developments in biologicals. ,vol. 119, pp. 113- 127 ,(2004)
Armin R.W. Elbers, Anoek Backx, Estelle Meroc, Guillaume Gerbier, Christoph Staubach, Guy Hendrickx, Arco van der Spek, Koen Mintiens, Field observations during the bluetongue serotype 8 epidemic in 2006 - I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands Preventive Veterinary Medicine. ,vol. 87, pp. 21- 30 ,(2008) , 10.1016/J.PREVETMED.2008.06.004
E.Paul J. Gibbs, Ellis C. Greiner, The epidemiology of bluetongue Comparative Immunology Microbiology and Infectious Diseases. ,vol. 17, pp. 207- 220 ,(1994) , 10.1016/0147-9571(94)90044-2
Sidney Siegel, Nonparametric statistics for the behavioral sciences ,(1956)
G. Savini, C. Hamers, A. Conte, P. Migliaccio, B. Bonfini, L. Teodori, M. Di Ventura, P. Hudelet, C. Schumacher, V. Caporale, Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Veterinary Microbiology. ,vol. 133, pp. 1- 8 ,(2009) , 10.1016/J.VETMIC.2008.05.032
José-Manuel Sánchez-Vizcaino, Stéphan Zientara, Giovanni Savini, N. James MacLachlan, Vaccines against bluetongue in Europe Comparative Immunology Microbiology and Infectious Diseases. ,vol. 31, pp. 101- 120 ,(2008) , 10.1016/J.CIMID.2007.07.006
C. Hamers, S. Galleau, R. Chery, M. Blanchet, S. Goutebroze, L. Besancon, C. Cariou, B. Werle-Lapostolle, P. Hudelet, Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle. Veterinary Record. ,vol. 165, pp. 369- 373 ,(2009) , 10.1136/VR.165.13.369
N.James MacLachlan, The pathogenesis and immunology of bluetongue virus infection of ruminants Comparative Immunology Microbiology and Infectious Diseases. ,vol. 17, pp. 197- 206 ,(1994) , 10.1016/0147-9571(94)90043-4
Claude Saegerman, Dirk Berkvens, Philip S. Mellor, Bluetongue epidemiology in the European Union. Emerging Infectious Diseases. ,vol. 14, pp. 539- 544 ,(2008) , 10.3201/EID1404.071441
J. Gethmann, K. Hüttner, H. Heyne, C. Probst, M. Ziller, M. Beer, B. Hoffmann, T.C. Mettenleiter, F.J. Conraths, Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions Vaccine. ,vol. 27, pp. 4118- 4126 ,(2009) , 10.1016/J.VACCINE.2009.04.072